Horizon Therapeutics
HZNP
#739
Rank
NZ$47.10 B
Marketcap
$205.70
Share price
0.00%
Change (1 day)
17.66%
Change (1 year)

Revenue for Horizon Therapeutics (HZNP)

Revenue in 2023 (TTM): NZ$5.97 Billion

According to Horizon Therapeutics 's latest financial reports the company's current revenue (TTM ) is NZ$6.44 Billion. In 2022 the company made a revenue of NZ$5.71 Billion an increase over the revenue in the year 2021 that were of NZ$4.72 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Horizon Therapeutics from 2009 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) NZ$5.97 B4.62%
2022 NZ$5.71 B21.01%
2021 NZ$4.72 B54.89%
2020 NZ$3.04 B57.99%
2019 NZ$1.93 B7.22%
2018 NZ$1.80 B21.05%
2017 NZ$1.48 B5%
2016 NZ$1.41 B28.05%
2015 NZ$1.10 B191.85%
2014 NZ$0.37 B320.79%
2013 NZ$90.07 M277.42%
2012 NZ$23.86 M168.88%
2011 NZ$8.87 M188.19%
2010 NZ$3.07 M
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NZ$57.54 B 792.71%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$90.56 B 1,305.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$106.31 B 1,549.40%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$6.35 B-1.38%๐Ÿ‡ฎ๐Ÿ‡ณ India
NZ$111.73 B 1,633.45%๐Ÿ‡บ๐Ÿ‡ธ USA